- ARRIVAL AND INSTALLATION OF G-CON CLEANROOM PODS ARE A KEY MILESTONE FOR THE J.POD FACILITY AT EVOTEC’S CAMPUS CURIE IN TOULOUSE, FRANCE
- JUST – EVOTEC BIOLOGICS’ J.POD TECHNOLOGY OFFERS A PARADIGM SHIFT IN BIOMANUFACTURING WITH COST-EFFECTIVE AND TRULY FLEXIBLE CLINICAL AND COMMERCIAL SUPPLY SOLUTIONS
Hamburg, Germany, and Toulouse, France, 14 June 2023:
Evotec SE (Frankfurt Stock Exchange: EVT, ISIN: DE0005664809; NASDAQ: EVO) today announced the successful arrival and start of installation of the cleanroom PODs at its J.POD biologics manufacturing facility located on Evotec’s Campus Curie in Toulouse, France. Manufactured and delivered by G-CON, a global leader in off-site pre-fabricated cleanroom systems, the cleanroom PODs will be installed over the next few weeks. G-CON previously supplied the cleanroom PODs for the first J.POD facility at Just – Evotec Biologics’ site in Redmond, WA (US) in August 2021.
The installation is an important step towards the completion of J.POD Toulouse, France (EU), the second facility of its kind and the first one on European ground. The GMP biomanufacturing facility features intensified, continuous bioprocessing operations housed inside autonomous cleanroom PODs, and will provide low cost clinical and commercial manufacturing capacity for biologics.
Dr Linda Zuckerman, Executive Vice President, Global Head Biotherapeutics at Just – Evotec Biologics, commented: “The installation of multiple cleanroom PODs by the G-CON team advances the construction of J.POD Toulouse, France (EU) significantly. The PODs are one of the cornerstones for our continuous manufacturing platform enabling advanced and efficient biomanufacturing processes available to our partners for the benefit of patients worldwide.”